Frequency of Gastrointestinal and Hepatic Manifestations Among Patients with Multiple Sclerosis, a Clinical Hospital Based Study
1 other identifier
observational
80
0 countries
N/A
Brief Summary
The aim of this work is to identify different pattern of Gastrointestinal and Hepatic symptoms and its Frequency among patients with Multiple Sclerosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 27, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 13, 2025
January 1, 2025
1.9 years
December 27, 2024
January 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Detection of Prevalence of git and hepatic manifestation in people with MS and its relations to MS treatment
24 month
Eligibility Criteria
both genders people on remission any age
You may qualify if:
- both sex 2- All patients diagnosed MS ( in recovery on DMT) according to the 2017-McDonalds criteria.
- Pt with MS suffer from git and hepatic symptoms not explained by known cause as Hepatitis virus،metabolic disorders as Wilson . hemochromatosis,etc Drug induced , Alcohol , Git symptoms as dysphagia, vomiting,reflux
- An informed consent will be obtained from all the patients, the study will be approved by ethical committee in faculty of Medicine Assiut University
You may not qualify if:
- \_ Presence of other disorder or on medications that may affect the neurological or GIT disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Levinthal DJ, Rahman A, Nusrat S, O'Leary M, Heyman R, Bielefeldt K. Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis. Mult Scler Int. 2013;2013:319201. doi: 10.1155/2013/319201. Epub 2013 Sep 17.
PMID: 24163768BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
December 27, 2024
First Posted
January 13, 2025
Study Start
January 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 13, 2025
Record last verified: 2025-01